RA Capital Management »

Corvus Pharmaceuticals shares owned by RA Capital Management

Quarter-by-quarter ownership of Corvus Pharmaceuticals (CRVS) shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Corvus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Corvus Pharmaceuticals held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corvus Pharmaceuticals by RA Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $6.6M 450k 14.63

More positions owned by RA Capital Management

Ascendis Pharma A/s - Sponsored Adr (ASND)
Vaxcyte Common Stock (PCVX)
Rhythm Pharmaceuticals Common Stock (RYTM)
Tyra Biosciences Common Stock (TYRA)
Sionna Therapeutics Common Stock (SION)
Edgewise Therapeutics Common Stock (EWTX)
Newamsterdam Pharma Co Nv Common Stock (NAMS)
Nuvalent Inc-a Common Stock (NUVL)
Dianthus Therapeutics Common Stock (DNTH)
Mineralys Therapeutics Common Stock (MLYS)
Spyglass Pharma Common Stock
Wave Life Sciences Common Stock (WVE)
Septerna Common Stock (SEPN)
Disc Medicine Common Stock (IRON)
Janux Therapeutics Common Stock (JANX)

View all positions for RA Capital Management

Top funds holding Corvus Pharmaceuticals

OrbiMed Advisors
BlackRock
Vanguard Group
Adams Street Partners
Vanguard Capital Management
Vivo Capital
State Street Corporation
Morgan Stanley
Deep Track Capital
Perceptive Advisors
Commodore Capital
Foresite Capital Management VI
Braidwell
Geode Capital Management
MPM Oncology Impact Management

View all funds holding Corvus Pharmaceuticals